This video offers an introduction to the OMICROHN Study, developed within the Horizon Europe project METHYLOMIC, in which IFCCA is a participating member. With contributions from Prof. Jack Satsangi, Dr Alexandra Noble, Prof. Geert D’Haens, and patient representative Marieke Oosting, the video explores how epigenetics and DNA methylation could support a more personalised and forward-looking approach to inflammatory bowel disease care.
Inside the OmiCrohn Study